secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0001104659-24-077718
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

NWBO annual meeting re-elects directors, ratifies auditor and option awards, approves exec comp
--------------------------------------------------------------------------------

- Re-elected Dr. Alton L. Boynton (94.04% for) and Ambassador J. Cofer Black (93.01% for) as Class I directors for three-year terms.
- Ratified Cherry Bekaert LLP as independent auditor for FY2024 with 92.73% of votes cast in favor.
- Ratified 2020 option awards to named executive officers (88.13% for) and non-executive directors (88.05% for).
- Advisory approval of 2023 executive compensation received 87.37% of votes cast in favor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924077718/0001104659-24-077718-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924077718/tm2418878d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-077718

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer